Clinical trial Recruiting at 1 site Interventional Ages 18 and up

LiveWell: a tailored DBT skills program for people living with metastatic lung cancer

Official title: LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living With Metastatic Lung Cancer

Run by Medical University of South Carolina · NCT07177846 · Data updated 2026-11-12

This pilot randomized trial tests a telehealth DBT skills program called LiveWell for adults with metastatic non-small cell lung cancer and distress to see if it reduces distress and improves well-being compared to usual care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorMedical University of South Carolina
Academic / other
Locations1 site (Charleston, South Carolina)
StatusRecruiting
StartedOctober 15, 2026
Main results expectedOctober 1, 2027
Study endsMarch 1, 2028
Registry record updatedOctober 7, 2026
Trial IDNCT07177846 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older with AJCC stage IV NSCLC, receiving non-curative treatment or active surveillance, English-speaking, with distress (score ≥3/10) and at least one emotional concern, able to consent.

Probably not a fit

Patients with very limited life expectancy, cognitive impairment, untreated serious mental illness, or those unable to participate in telehealth may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized controlled trial enrolls 80 adults with metastatic non-small cell lung cancer and at least mild distress. Participants are randomized 1:1 to receive an eight-session telehealth-delivered LiveWell Dialectical Behavior Therapy Skills Training program tailored for lung cancer metavivors or usual care. Outcomes include feasibility and acceptability, with preliminary efficacy on distress (primary) and quality of life, symptom burden, and psychological well-being (secondary), assessed at baseline, 9 weeks, and 3 months. The study also explores emotion regulation as a potential mechanism of change. The intervention is delivered remotely to accommodate treatment schedules and disease burden.

Why it matters

Potential benefit: If successful, LiveWell could reduce emotional distress and improve quality of life for patients with advanced lung cancer.

How similar studies have gone: DBT-based psychosocial interventions have shown promise in oncology settings, but this specific adapted, telehealth DBT for metastatic lung cancer is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18
* AJCC Stage IV non-small cell lung cancer
* Receiving treatment with non-curative intent or on active surveillance
* English proficiency
* Able to provide informed consent
* National Comprehensive Cancer Network distress screening score ≥ 3/10 plus endorse at least 1 emotional concern.

Exclusion Criteria:

* Cognitive impairment
* Untreated serious mental illness
* Expected survival \< 6 months

Where it's running

  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Kelly Hyland, PhD — Medical University of South Carolina
  • Study coordinator: Benjamin Axelrod
  • Email: axelrod@musc.edu
  • Phone: 843-876-2645

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.